These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16750364)

  • 41. Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice.
    Nonogaki K; Kaji T; Ohba Y; Sumii M; Wakameda M; Tamari T
    Biochem Biophys Res Commun; 2009 Aug; 386(2):311-5. PubMed ID: 19523439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan.
    Kamei K; Maeda N; Nomura K; Shibata M; Katsuragi-Ogino R; Koyama M; Nakajima M; Inoue T; Ohno T; Tatsuoka T
    Bioorg Med Chem; 2006 Mar; 14(6):1978-92. PubMed ID: 16290165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.
    Bernotas RC; Lenicek S; Antane S; Cole DC; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Platt B; Lin Q; Li P; Coupet J; Rosenzweig-Lipson S; Beyer CE; Schechter LE
    Bioorg Med Chem; 2009 Jul; 17(14):5153-63. PubMed ID: 19523834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: hit-to-lead optimization.
    Fish PV; Brown AD; Evrard E; Roberts LR
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1871-5. PubMed ID: 19269173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists.
    Richter HG; Adams DR; Benardeau A; Bickerdike MJ; Bentley JM; Blench TJ; Cliffe IA; Dourish C; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Monck NJ; Plancher JM; Roever S; Roffey JR; Taylor S; Vickers SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1207-11. PubMed ID: 16361098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation.
    Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA
    Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia.
    Samad N; Haleem MA; Haleem DJ
    Pak J Pharm Sci; 2008 Jul; 21(3):262-8. PubMed ID: 18614422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors.
    Blaazer AR; Smid P; Kruse CG
    ChemMedChem; 2008 Sep; 3(9):1299-309. PubMed ID: 18666267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory molecules for the 5-HT3 receptor ion channel gating system.
    Yoshida S; Watanabe T; Sato Y
    Bioorg Med Chem; 2007 May; 15(10):3515-23. PubMed ID: 17391967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
    Nonogaki K; Ohba Y; Sumii M; Oka Y
    Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of potent and subtype-selective PPARalpha agonists.
    Desai RC; Metzger E; Santini C; Meinke PT; Heck JV; Berger JP; MacNaul KL; Cai TQ; Wright SD; Agrawal A; Moller DE; Sahoo SP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1673-8. PubMed ID: 16384704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
    Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
    Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists.
    Dounay AB; Barta NS; Bikker JA; Borosky SA; Campbell BM; Crawford T; Denny L; Evans LM; Gray DL; Lee P; Lenoir EA; Xu W
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1159-63. PubMed ID: 19147349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist.
    Franchini S; Tait A; Prandi A; Sorbi C; Gallesi R; Buccioni M; Marucci G; De Stefani C; Cilia A; Brasili L
    ChemMedChem; 2009 Feb; 4(2):196-203. PubMed ID: 19101959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.
    Feng Z; Mohapatra S; Klimko PG; Hellberg MR; May JA; Kelly C; Williams G; McLaughlin MA; Sharif NA
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2998-3002. PubMed ID: 17419053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of acute intra-cerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats.
    Hadamitzky M; Koch M
    Behav Brain Res; 2009 Dec; 204(1):88-92. PubMed ID: 19467270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.